Læknablaðið : fylgirit - 01.05.1978, Qupperneq 76

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 76
O. Strandberg, M. D. , Department of Rheuma- tology, Danderyd Hospital, Sweden. Elisabeth Wijnbladh, M. D., Saltsjöbaden Hospital, Stockholm, Sweden. FerastralW, Astra 2152, is a sterile solution of a complex of iron and a sorbitol glueonic acid polymer, containing 50 mg Fe+++/ml. The preparation can be used in relatively large doses (500 mg) with 3-7 day's interval (Andersson, Grafford, 1975, Swedberg, 1975). In this study, 15 patients with moderate anaemia and subnormal MCHC were treated with Ferastral. In all the patients inflammatory processes, in most cases active rheumatoid arthritis, was the underlying cause. Diagnostic criteria according to American Rheumatism Association were fulfilled. Concomitant therapy consisted of usual anti-inflammatory drugs, such as salicylates, indomethacin, naproxene, and in some cases very low doses of penicillamine. Local therapy with corticosteroids íh very small doses was also used in some cases. The corticosteroid doses thus given were too small to affect the haematopoetic system (Strandberg, 1966). The total doses in mg were estimated by multiplying the haemoglobin deficit in mg/100 ml. by 225 (Brown & Moore, 1956) plus 500 mg for the iron stores. Another method to estimate the expected total iron dose to be given is to multiply desired haematocrit rise by 100 (Mc Curdy, 1970). The total doses given ranged between 1250 mg and 3500 mg, the major part of the patients receiving about 2000 mg. It was given in single doses of 500 mg with an interval of about one week. 3 patients received lower single doses of 250 and 100 mg. Laboratory methods: Haemoglobin was determined by the cyan methaemoglobin method. Erythrocytes were counted in a Coulter counter, and the packed cell volume was determined after 5 minutes centrifuga- tion in a haematocrit centrifuge. Serum iron concentration was determined according to Heil- meyer and Plötner (1937) and UIBC according to Cartwright and Wintrobe (1949). Agarose gel electrophoresis according to H Johansson (1972). Serum albumin concentration according to Doumas (1971) and haptoglobin (Tai-ukoski, 1966) were determined with chemical methods. Alpha-1- FERESTRAL IN THE TREATMENT OF PATIENTS WITH INF LAMMATORY ANAEMIA trypsine, orosomucoid, C'3, C’4 complement fractions, immune globulins G, A, M and trans- ferrin were determined with electro immune assay (Laurell 1972). R esults : The haemoglobin data during the observation period and at least 6 weeks after the start of the trial - the majority of the patients were followed for 8-12 weeks - have been tabulated in every detail, but are not discussed in detail. The statistical treatment of the pertinent data are tabulated (table 2). Every patient served as in its own control and the t-value for the differences between the means for 4 and 8 weeks and the means at the beginning of treatment were calculated. The haemoglobin concentration rose after 8 weeks significantly (P < 0.001) from 109.2 to 122.6 g/1. Although the means for the packed cell volumes displayed a rising tendency, the differences 4 and 8 weeks after the last injection were not statisti- cally significant. The erythrocyte count rose from 4.06 to 4.24 x 106/mm3 (0.1 > P > 0.01). The MCHC means rose from 317 to 334 g/1 (0.01> P> 0.001) at 8 weeks and after 4 weeks from 317 to 324 (0.1 > P > 0.01). The mean serum iron concentration beginning with 40.4 mg/100 ml rose to 68.9 (0. 01 > P> 0.001). The UIBC decreased from 279.3 to 171.8 mg/ml (0.01> P> 0.001). In the small series of trans- ferrin determinations, the same tendency as for UBBC was obtained. The mean decreased from 1.95 to 1.40 g/1 after 8 weeks (0.1 > P> 0. 01). No changes were obtained in the agarose electrophoresis pattern, nor in the serum protein components. Only C’4 showed slightly rising tendency, from 0.16 to 0.20 g/1 (0.1> P > 0. 01). Liver and kidney tests were followed during the test period, without changes (Add. No. 8). Side effects: A brownish discolouration at the injection site was observed in 8/17 patients receiving this iron 74
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.